Eszopiclone Tablet, Film Coated
Product Images NDC 60429-634

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eszopiclone (NDC 60429-634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60429 632 30lb

60429 632 30lb
This is a prescription medication labeled NDC 60429-632-30, containing 30 film-coated tablets of Eszopiclone USP 1mg, used for treating insomnia. The recommended dosage for an adult is one tablet taken at bedtime. The medication guide, available at https://gsms.us/, should be dispensed to every patient. It should be stored in a cool and dry place at room temperature, and sealed with a tight and child-resistant cap. It is manufactured by Alphapharm Pty Ltd and marketed by GSMS, Inc. Note the prescription is recommended for individual use only and should not be shared with other people.*
FDA Label Image

60429 633 30lb

60429 633 30lb
This is a description for a medication called Eszopiclone. It is a film-coated tablet containing 2mg of the active ingredient. The usual adult dosage is one tablet before bedtime. The medication guide should be provided to each patient and the container should be tightly closed and kept away from reach of children. It should be stored at a temperature of 20-25°C. The medication is manufactured by ALPHAPHARM PTY LTD and marketed by GSMS Incorporated. This product is available only with a prescription.*
FDA Label Image

60429 634 30lb

FDA Label Image

Eszopiclone Structural Formula (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.